WAUSAU, Wis. (WSAW) - In the past, being diagnosed with small-cell lung cancer seemed to be a death sentence. This type of cancer is known as one of the most aggressive and deadliest forms of cancer.
New drugs have made America’s deadliest cancer more treatable than ever. So why aren’t they reaching patients?
When patients are looking for options in the face of sudden, severe illness, the latest treatments are often their main source of hope. Even for individuals who have struggled with lung disease for ...
Immunotherapy is a cancer treatment that harnesses the body’s immune system to fight cancer. It helps the immune system recognize and attack cancer cells, which can sometimes be hidden from the body’s ...
Denise Lee grew up in Detroit in the mid-1970s and went to an all-girls Catholic high school. She smoked her first cigarette at age 14 at school, where cigarettes were a popular way of trying to lose ...
The Food and Drug Administration on Thursday approved Amgen's treatment for patients with the most deadly form of lung cancer. The agency cleared the drug, called Imdelltra, as a second or later-line ...
Please provide your email address to receive an email when new articles are posted on . Creation Healthcare analyzed 1,462 English language posts on X by 1,050 health care professionals. Health care ...
Small cell lung cancer (SCLC) often responds well to initial treatment before later relapsing. Researchers are continuing to investigate new treatments, such as targeted therapy and immunotherapy ...
A new study by Duke researchers marked a major shift in understanding one of the deadliest forms of lung cancer. On Wednesday, researchers released a new study that found small cell lung cancer (SCLC) ...
University of Virginia School of Medicine scientists have discovered how severe COVID-19 can destroy immune cells' ability to repair the lungs, helping explain the lingering effects of long COVID. The ...
Immunotherapy and targeted therapies have significantly improved NSCLC treatment, with ADCs and genomic alterations offering new avenues. CLL advancements include BTK inhibitors and MRD measurement, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results